The Journal of Allergy and Clinical Immunology
Volume 114, Issue 5 , Pages 1195-1201, November 2004

Peanut allergy: Recurrence and its management

  • David M. Fleischer, MD

      Affiliations

    • From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore
  • ,
  • Mary Kay Conover-Walker, MSN, RN, CRNP

      Affiliations

    • From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore
  • ,
  • Lynn Christie, MS, RD, LD

      Affiliations

    • Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital
  • ,
  • A. Wesley Burks, MD

      Affiliations

    • Department of Pediatrics, Duke University School of Medicine, Durham
  • ,
  • Robert A. Wood, MD

      Affiliations

    • From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore
    • Corresponding Author InformationReprint requests: Robert A. Wood, MD, Johns Hopkins Hospital, CMSC 1102, 600 N Wolfe Street, Baltimore, MD 21287.

Received 16 July 2004; received in revised form 18 August 2004; accepted 24 August 2004.

Baltimore, Md, Little Rock, Ark, and Durham, NC

Background

Although peanut allergy may recur, the frequency with which this occurs is unknown.

Objective

The goals of this study were to determine the rate of peanut allergy recurrence, identify risk factors for recurrent peanut allergy, and develop specific recommendations for the treatment of patients with resolved peanut allergy.

Methods

Children who outgrew peanut allergy were evaluated with questionnaires, skin tests, and peanut-specific IgE levels. Patients were invited to undergo a double-blind, placebo-controlled food challenge (DBPCFC) unless the history of a possible recurrence reaction was so convincing that a challenge would be potentially dangerous.

Results

Sixty-eight patients were evaluated. Forty-seven patients continued to tolerate peanut, of whom 34 ingested concentrated peanut products at least once per month and 13 ate peanut infrequently or in limited amounts but passed a DBPCFC. The status of 18 patients was indeterminate because they ate peanut infrequently or in limited amounts and declined to have a DBPCFC. After excluding 12 patients originally diagnosed with peanut allergy based solely on a positive skin prick test or peanut-specific IgE level, 3 of 15 patients who consumed peanut infrequently or in limited amounts had recurrences, compared with no recurrences in the 23 patients who ate peanut frequently (P=.025). The recurrence rate was 7.9 (95% CI, 1.7% to 21.4%).

Conclusion

Children who outgrow peanut allergy are at risk for recurrence, and this risk is significantly higher for patients who continue largely to avoid peanut after resolution of their allergy. On the basis of these findings, we now recommend that patients eat peanut frequently and carry epinephrine indefinitely until they have demonstrated ongoing peanut tolerance.

Key words: Peanut allergy, recurrence, food challenge, RAST, food hypersensitivity

Abbreviations used: DBPCFC, Double-blind, placebo-controlled food challenge, FEIA, Fluorescent-enzyme immunoassay, kUA/L, Kilounits of antibody per liter, PN-IgE, Peanut-specific IgE, SPT, Skin prick test

 

 Supported by National Institutes of Health training grant T32 AI 07007 from the National Institute of Allergy and Infectious Disease, the Eudowood Foundation for the Consumptives of Maryland, the Myra Reinhard Family Foundation, and General Clinical Research Center grants M01-RR000052 and M01-RR14288.

PII: S0091-6749(04)02290-0

doi:10.1016/j.jaci.2004.08.035

The Journal of Allergy and Clinical Immunology
Volume 114, Issue 5 , Pages 1195-1201, November 2004